Patients positive for SSA/SSB more often present with organ involvement, leukopenia, hypergammaglobulinaemia and high disease activity measured by the European League Against Rheumatism Disease Activity Index (ESSDAI), compared with antibody‐negative patients 49, 50. The gene discussed is TRIM21; the disease is Decreased total leukocyte count.